• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

11-羟基-9-四氢大麻酚:大麻在人体内一种主要代谢物的药理学、分布及代谢

11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.

作者信息

Lemberger L, Crabtree R E, Rowe H M

出版信息

Science. 1972 Jul 7;177(4043):62-4. doi: 10.1126/science.177.4043.62.

DOI:10.1126/science.177.4043.62
PMID:5041775
Abstract

11-Hydroxy-Delta(9)-tetrahydrocannabinol, administered intravenously to man, produces psychologic and pharmacologic effects that persist for several hours. The drug and its metabolites are excreted in urine and feces for more than 1 week. The pharmacology, disposition, and metabolism of 11-hydroxy-Delta(9)-tetra-hydrocannabinol mimic that of Delta(9)-tetrahydrocannabinol, thus providing evidence that Delta(9)-tetrahydrocannabinol (the major active component of marihuana) is converted to the 11-hydroxy compound in man, the latter compound being responsible for the effects.

摘要

11-羟基-Δ(9)-四氢大麻酚静脉注射给人体后,会产生持续数小时的心理和药理作用。该药物及其代谢产物在尿液和粪便中排泄超过1周。11-羟基-Δ(9)-四氢大麻酚的药理、处置和代谢与Δ(9)-四氢大麻酚相似,从而证明Δ(9)-四氢大麻酚(大麻的主要活性成分)在人体内会转化为11-羟基化合物,后者产生这些作用。

相似文献

1
11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.11-羟基-9-四氢大麻酚:大麻在人体内一种主要代谢物的药理学、分布及代谢
Science. 1972 Jul 7;177(4043):62-4. doi: 10.1126/science.177.4043.62.
2
Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.Δ9-四氢大麻酚及其代谢物11-羟基-Δ9-四氢大麻酚的比较药理学
J Clin Invest. 1973 Oct;52(10):2411-7. doi: 10.1172/JCI107431.
3
Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
Clin Pharmacol Ther. 1974 Apr;15(4):380-6. doi: 10.1002/cpt1974154380.
4
Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.大麻:关于Δ⁹-四氢大麻酚在人体内的处置和代谢研究。
Science. 1970 Dec 18;170(3964):1320-2. doi: 10.1126/science.170.3964.1320.
5
Delta-9-tetrahydrocannabinol: metabolism and disposition in long-term marihuana smokers.
Science. 1971 Jul 2;173(3991):72-4. doi: 10.1126/science.173.3991.72.
6
A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
Experientia. 1973 Aug 15;29(8):1009-10. doi: 10.1007/BF01930433.
7
Pharmacology of orally administered 9 -tetrahydrocannabinol.口服9-四氢大麻酚的药理学
Clin Pharmacol Ther. 1973 Jan-Feb;14(1):48-55. doi: 10.1002/cpt197314148.
8
A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
Experientia. 1973 Nov 15;29(11):1368-9. doi: 10.1007/BF01922823.
9
Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
Science. 1972 Aug 18;177(4049):633-5. doi: 10.1126/science.177.4049.633.
10
Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis.δ-9-四氢大麻酚的作用。活性代谢物假说的一种研究方法。
Clin Pharmacol Ther. 1975 Dec;18(6):714-9. doi: 10.1002/cpt1975186714.

引用本文的文献

1
Pharmacokinetic/Pharmacodynamic Modeling of the Acute Heart Rate Effects of Delta-9 Tetrahydrocannabinol and Its Major Metabolites After Intravenous Injection in Healthy Volunteers.静脉注射Δ⁹ 四氢大麻酚及其主要代谢产物后对健康志愿者急性心率影响的药代动力学/药效学模型
Eur J Drug Metab Pharmacokinet. 2025 May;50(3):229-242. doi: 10.1007/s13318-025-00941-8. Epub 2025 Apr 5.
2
Evaluation of Cannabis Per Se Laws: A Semi-Mechanistic Pharmacometrics Model for Quantitative Characterization of THC and Metabolites in Oral Users.大麻本身相关法律的评估:一种用于定量表征口服使用者体内四氢大麻酚及其代谢物的半机制药代动力学模型。
J Clin Pharmacol. 2025 May;65(5):535-549. doi: 10.1002/jcph.6181. Epub 2025 Jan 20.
3
An emerging trend in Novel Psychoactive Substances (NPSs): designer THC.
新型精神活性物质(NPSs)的一个新趋势:合成大麻素。
J Cannabis Res. 2024 May 3;6(1):21. doi: 10.1186/s42238-024-00226-y.
4
CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1).CYP2C9、CYP3A 和 CYP2C19 将 Δ9-四氢大麻酚代谢为多种代谢物,但代谢受人体肝脂肪酸结合蛋白(FABP1)的影响。
Biochem Pharmacol. 2024 Oct;228:116191. doi: 10.1016/j.bcp.2024.116191. Epub 2024 Apr 5.
5
Cannabinoid-Induced Inhibition of Morphine Glucuronidation and the Potential for In Vivo Drug-Drug Interactions.大麻素诱导的吗啡葡萄糖醛酸化抑制作用及体内药物相互作用的可能性。
Pharmaceutics. 2024 Mar 18;16(3):418. doi: 10.3390/pharmaceutics16030418.
6
The impact of pregnancy and associated hormones on the pharmacokinetics of Δ-tetrahydrocannabinol.妊娠及相关激素对Δ-四氢大麻酚药代动力学的影响。
Expert Opin Drug Metab Toxicol. 2024 Jan-Feb;20(1-2):73-93. doi: 10.1080/17425255.2024.2309213. Epub 2024 Mar 4.
7
Pharmacokinetics and central accumulation of delta-9-tetrahydrocannabinol (THC) and its bioactive metabolites are influenced by route of administration and sex in rats.在大鼠中,药物代谢动力学和 delta-9-四氢大麻酚(THC)及其生物活性代谢物的中枢积累受给药途径和性别影响。
Sci Rep. 2021 Dec 14;11(1):23990. doi: 10.1038/s41598-021-03242-7.
8
Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes.目标 确定临床人群中大麻的使用水平对于检测药理学结果至关重要。
Cannabis Cannabinoid Res. 2022 Dec;7(6):852-864. doi: 10.1089/can.2021.0068. Epub 2021 Nov 18.
9
Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC.Δ9-四氢大麻酚半琥珀酸酯栓剂剂型作为Δ9-四氢大麻酚全身给药胶囊替代剂型的药代动力学及耐受性研究
Med Cannabis Cannabinoids. 2018 Jun 12;1(1):44-53. doi: 10.1159/000489037. eCollection 2018 Jun.
10
A review of the effects of acute and chronic cannabinoid exposure on the stress response.急性和慢性大麻素暴露对应激反应影响的综述。
Front Neuroendocrinol. 2021 Oct;63:100945. doi: 10.1016/j.yfrne.2021.100945. Epub 2021 Aug 28.